FLT1 and hepatocellular carcinoma: Previous studies have demonstrated that tumoral angiogenesis involving VEGF-A and its two receptors, VEGFR1/flt-1 and VEGFR-2/KDR, is associated with the prognosis of HCC patients [13–14].